LINDSEY KELLER: Open Payments
NPI 1871968305 · ELGIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$230 in 10 payments from 8 companies in 2025. Trend: 2023 $296 · 2024 $268 · 2025 $230
Food & beverage: $182Education: $47
| Company | Payments | Amount |
|---|---|---|
| OPKO Pharmaceuticals, LLC | 2 | $47 |
| Fresenius USA Marketing, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Calliditas Therapeutics US Inc. | 1 | $26 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| SCPHARMACEUTICALS INC. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
Products named: RAYALDEE, VELPHORO, JYNARQUE, TARPEYO, FUROSCIX, FARXIGA, KEVEYIS.
Industry payments across IL — which companies pay providers there.
